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ABSTRACT  
  
A number of different methods to generate stratified keratinocyte layers have been published. These 
involved the use of normal human epidermal keratinocytes (NHEKs/NEKS), which have a better 
ability to stratify compared to HaCaT keratinocytes, which usually require supplemented growth 
factors or stromal interactions with fibroblasts to do so.   
  
X
IV  
  
This study aimed to generate a model of stratified keratinocytes, closely resembling in vivo skin, 
using HaCaT cells and to demonstrate the effect that C. trachomatis has on these layered 
keratinocytes, allowing us to gain insight on the pathophysiology of this organism.  
  
All cells and bacteria were propagated and titrated according to conventional protocols.  HaCaT cells 
were subcultured upon confluence, seeded (1x106 cells/ml) onto collagen-coated PTFE Transwell 
membrane inserts and incubated at 33°C and 37°C for 24 days to allow differentiation and 
stratification.  Once cells became confluent they were exposed to the air-liquid interface and fed with 
KGM Gold (Lonza) supplemented with 10% FBS and additional calcium. Thereafter, cells were fixed 
in 3.7% phosphate-buffered formaldehyde, embedded in a paraffin block, sectioned, stained and 
viewed.  Hematoxylin and Eosin (H&E) staining was used to determine the resemblance to in vivo 
human skin. Immunofluorescence was used to detect keratin 10, keratin 14 and involucrin which are 
markers of keratinocyte differentiation.  Stratified keratinocyte layers were infected with C.  
trachomatis and this was confirmed using the MicroTrak ® C. trachomatis Culture Confirmation Test 
Kit. Subsequent changes to the layers were also observed and recorded.   
  
It was shown that HaCaT cells grown at the air-liquid interface on collagen-coated PTFE Transwell 
membrane inserts were able to stratify at 33°C. However, more layers of keratinocytes were seen at 
37°C after the same duration of incubation (24 days). Keratin 10, keratin 14 and involucrin were all 
detected in the layers grown at both temperatures, suggesting that the keratinocytes had committed to 
differentiation. However, the fluorescence seen at 33°C for keratin 10 and involucrin was more 
intense as compared to that seen at 37°. This suggests that although stratification was faster at 37°C, 
differentiation was quicker at 33°C.   
  
  
X
V   
C. trachomatis was able to infect layered keratinocytes grown at both temperatures although not all 
layers formed at 33°C were infected. Degradation of keratinocyte layers after infection with C.  
trachomatis was more prominent in those grown at 37°C, which is in keeping with previous findings 
that the optimum growth temperature of the C. trachomatis LGV biovar is 37°C.  
  
This study provided a novel insight in suggesting the manner in which C. trachomatis is able to infect 
and migrate through in vivo skin, leaving room for further studies in which similar methods of 
generating stratified keratinocytes may be used to better understand the pathophysiology of various 
other organisms that affect keratinocytes. 
   
CHAPTER 1 – INTRODCUTION   
  
Chlamydia trachomatis is a gram negative, sexually transmitted pathogen with a characteristic obligate 
intracellular life cycle, essential for survival (Caldwell et al. 1981).  
Chlamydiae predominantly infects columnar epithelial cells, causing an inflammatory response which 
further orchestrates both, an innate and adaptive immune response (O’Connel et al. 2006).   
C.trachomatis is associated with a number of various diseases (Bobo et al. 1997). In 1995, the World 
Health Organization (WHO) reported 89 million new findings of genital Chlamydia infections, 
indicative of the effect that chlamydial infections have on a global scale, and the economic strain it 
causes (Schachter, 1999). More specifically, the lymphogranuloma venereum (LGV) serovars L1, L2 
and L3 cause a more invasive sexually transmitted disease called Lymphogranuloma venereum 
(Schachter, 1999). This invasive bacterium travels down the lymphatic channels after passing through 
the epithelial cell layer. Thereafter, multiplication occurs within mononuclear phagocytes of the 
lymph nodes (Belland et al, 2004). Invasion of the lymphatic tissue ultimately results in severe 
clinical symptoms such as abscesses, lymphatic fibrosis, elephantiasis of genetalia, and anal strictures 
(Mabey and Peeling, 2002).   
Cases of LGV infections are common in Africa, the Caribbean and parts of Asia (Perine and Stamm, 
1999). In 2003, more modern and revolutionized countries suffered an epidemic of LGV in 
homosexual males, where outbreaks of LGV proctitis were commonly reported in the Netherlands and 
Western Europe, despite the misconception of being relatively rare in modern times. (Nieuwhenhuis 
et al, 2004).  
Previous studies that investigated the in vitro infection of C.trachomatis in keratinocytes were only 
conducted on monolayers of human keratinocytes, which does not constitute part of the human in vivo 
environment. Therefore, these studies did not give a clear depiction of the pathogenesis of the 
organism.   
2  
  
This study aims to generate a stratified keratinocyte model in vitro, which closely resembles the in 
vivo human epidermis, using tissue-culture techniques. The model will then be infected with the 
C.trachomatis L2 reference strain, in an effort to assess the ability of C. trachomatis to migrate 
through the multi-layered human keratinocyte structure. Overall, the development of these 
keratinocyte infection models, in vitro, allows for a clearer understanding of the pathogenesis of 
Chlamydia trachomatis, essentially opening room for improving treatment of infected patients.   
  
This study was approved by the Research Ethics Committee of the Nelson R Mandela School of  
Medicine, University of KwaZulu Natal. Reference number: BE021/16 (sub-study of BE220/13).  
  
  
  
  
  
  
  
  
  
  
CHAPTER 2 – LITERATURE REVIEW   
  
2.1 Chlamydia trachomatis  
3  
  
Chlamydia trachomatis is a Gram negative bacterial pathogen which causes both genital tract 
and eye infections in humans. It comprises of 15 serovars (A, B, Ba, C-K and L1-L3), grouped 
based on antigenic differences in the chlamydial major outer membrane protein (MOMP) 
(Caldwell et al. 2003; Schachter, 1999; Mabey et al. 1999).   
  
The serovars are further grouped into biovars which differ in pathophysiology. Serovars A-C 
make up the trachoma biovar (Mabey et al. 1999), serovars D-K the urogenital biovar and L13 
the lymphogranuloma venereum (LGV) biovar (Moulder, 1991). The trachoma biovar consists 
of serovars Ab, B, Ba and C, which cause trachoma whereby the urogenital serovars D-K cause 
urethritis in male and urethritis and cervicitis in female (Carlson et al. 2004). Both, trachoma 
and urogenital strains have the ability to infect epithelial cells of the conjunctiva and genital 
tract respectively, thereby causing disease that is specific to the particular organ system (Miyairi 
et al. 2006). The range of diseases caused by the trachoma biovar is limited to chronic 
conjunctival infection, whereas, urogenital strains cause a wider range of both acute and chronic 
genital tract infections but also a form of active conjunctivitis (Leonard & Borel, 2014).   
Chlamydia of the LGV biovar are invasive (Schachter & Moncada, 2005) in the sense that these 
infect tissue underlying the primary target of epithelial cells. The other chlamydial biovars are 
non-invasive.   
Interestingly, the C trachomatis serovars have approximately 99.6% of shared DNA, even 
though there is a substantial variation in their respective disease spectrum, indicating that 
variations are as a result of a minute number of genetic differences (Carlson et al. 2004).  
C. trachomatis is transmitted through infected body secretions and infects mostly mucosal 
membranes namely; the cervix, rectum, urethra, throat and conjunctiva. The most common 
method of transmission of serovars D-K and L1-L3 is through sexual contact (Wang, 1999).  
  
2.2 Lymphogranuloma venereum (LGV)  
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LGV is an infection of the skin and lymphatic system caused by C. trachomatis of the LGV 
biovar (Schachter, 1983). The infection develops when the bacterium gets in contact with viable 
epithelial cells in the deeper layers of the skin. This results in the formation of a genital ulcer. 
From there, the bacteria pass through the epithelial cell layer and travel along the lymphatic 
channels towards the inguinal lymph nodes where it multiplies within mononuclear phagocytes 
causing inguinal lymphadenitis, the secondary stage of infection.  If left untreated, a tertiary 
stage may follow which involves the occurrence of fibrosis of the lymphatics, resulting in 
varying degrees of lymphatic obstruction, chronic oedema and strictures. These symptoms are 
usually irreversible (Ward et al. 2007).    
  
2.3 Biology  
2.3.1 Structure and morphology   
C. trachomatis is a gram negative obligate intracellular bacterium, which appears in two 
different forms (Ward 1983). The elementary body (EB) is the infectious, metabolically 
inactive form while the reticulate body (RB) is non-infectious, metabolically active and 
replicates (Ward 2002).  
The EB is small and compact with a ridged cell wall that provides osmotic resistance, thus 
rendering it more resilient during the transfer from one host cell to another (Ward 1983). It 
is spherical in shape with a diameter of approximately 350 nm (Ward 2002) and comprises 
of cytoplasm and compactly-packed DNA together with 3 binding-proteins, which are 
H1like proteins (Wagar & Stephens 1988). In human cells these H1 proteins maintain the 
overall structure of the chromatin network. Two of the H1-like proteins in chlamydia (Hcl 
and Hc2) are involved in condensation of the DNA when EB are formed. The activity of  
Hc1 is controlled by regulatory RNA (IntA) which prevents the transformation of RBs into 
EBs (Grieshaber et al. 2006).  
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The RB is much larger than the EB (Bavoil et al. 1984). It is pleomorphic in shape with a 
diameter of approximately 1μm (Ward 2002). Being metabolically active, RBs lack the 
chlamydial histone analogues that condense the nucleoid in EBs (Hacktadt et al. 1991). 
The diffuse nucleoid of RBs, allows transcription and synthesis of proteins (Ward 2002). 
Since C. trachomatis is a gram negative organism, both the EB and RB are surrounded by 
a cytoplasmic membrane and a layered cell wall (Ward, 1983). In a study by Matsumoto & 
Manire (1970), the cell walls of both EBs and RBs were examined and compared. It was 
found that the cell wall of the EB had a high phospholipid and amino-acid content, as 
expected in typical gram-negative organisms. However, the cell wall of the RB had a 
decreased amount of phospholipid, with no detectable amino-acids. Manire (1966) 
demonstrated that hexagonal subunits are synthesized during the maturation of RB to EB 
which form part of the interior of the cell wall. The chemical composition thereof remains 
unknown. Manire (1966) also elucidated that the synthesis of the subunits is prevented by 
penicillin and stated that the primary purpose of the subunits is to provide the cell wall of 
the EB with strength and rigidity, which is absent in the RB, making it more fragile in 
comparison. This layer of subunits is known as the P-layer (Matsumoto & Manire, 1970). 
The transformation from EB to RB is dependent on bacterial protein synthesis (Gerard et 
al, 1997). There is expression of chlamydial 16S rRNA during the transformation of EB to  
RB, making it a marker for both, replicating and viable non-replicating organisms 
(Mathews et al, 1999). Since rRNA constitutes part of the chlamydial ribosome, it is 
essential for function of the organism (Engel et al. 1987). Using reverse 
transcriptionpolymerase chain reaction assays, Gerard et al. 1997 tracked chlamydial RNA 
and discovered that transcripts from proximinal rRNA promotors are seen 4 hours after the 
EB binds to the host cell and distal rRNA promotors were detected 6 hours after infection, 
indicating that protein synthesis occurs at a very early stage during the transformation of 
EB to RB.   
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Like other Gram negative bacteria, the cell wall of C. trachomatis consists of a cytoplasmic 
membrane, a peptidoglycan (PG)-like layer and an outer membrane. However, the cell wall 
of this organism has a few unique structural features, namely no detectable muramic acid, 
atypical lipopolysaccharide (LPS) and a specific outer membrane protein (MOMP) (Liechi 
et al. 2014).   
Muramic acid, an amino sugar acid, is a component of peptidoglycan adding to the 
structural component of most bacterial cell walls (Liechi et al. 2014). It has been 
established that chlamydia has genes coding for PG and that they are susceptible to beta-
lactam antibiotics that target PG, even though PG as such is not detected in chlamydial 
species.  
This is known as the “chlamydia anomaly” (Ghuysen & Goffin 1999). Earlier studies 
elucidated the detection of muramic acid in small quantities in C.trachomatis from 
embryonated eggs (Jenkin, 1960). However, these studies made use of colorimetric 
methods which is not a reliable means of differentiating between smaller amounts of 
chemically similar compounds in complex mixtures. (Fox et al, 1990). In such cases, 
glucosamine and various amino sugars interfere in the colorimetric detection of muramic 
acid, which is common when muramic acid is found in small amounts (Fox et al, 1990). 
Furthermore, Fox et al, 1990, suggested that trace levels of muramic acid is not sufficient 
to synthesize a peptidoglycan, implying that the exact mechanism of action of antibiotics 
such as penicillin against chlamydiae remains unclear.    
Chlamydial LPS makes up part of the outer membrane of chlamydia. It differs from other 
gram-negative bacteria in that it has two of the three antigenic domains usually found in 
LPS (Weisburg et al. 1986). The cell wall is selectively permeable, thus protecting the EB 
whilst it is outside the host cell (Ghuysen & Goffin. 1999) and maintains a fixed shape and 
resilience to the stress of osmosis. Instead of muramic acid, sulphur bridges between 
cysteine-rich proteins allow for the rigid structure and ability to withstand osmotic pressure 
(Bavoil et al. 1984).  
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Chlamydia have a genus-specific LPS as part of the outer membrane (Brade et al. 1985). 
The key difference between chlamydial LPS and that of typical gram negative bacteria lies 
in the lipid-A moiety, comprising of 5 fatty acyl groups instead of the usual 6. The fatty 
acyl groups are long and comprise of normal fatty acids rather than hydroxyl fatty acids. 
This results in reduced endotoxicity of chlamydial LPS relative to that of typical bacteria 
(Heine et al. 2003). This allows chlamydia to develop asymptomatic cervicitis for which 
no treatment is sought.  From there chlamydia travel up the genital tract to the sterile 
oviducts causing infertility (Ingalls et al. 1995). These asymptomatic infections also allow 
for effective transmission.  
The outer membrane contains the major outer membrane protein (MOMP), which offers 
heterogeneity in 4 segments, each having different antigenic characteristics. This allows 
for the characterization of the strains into various serovars that can be identified by 
microimmunofluorescence (MIF) tests. In most specialised chlamydia laboratories, MIF is 
replaced by sequencing of the genes coding for the antigens (Stothard et al. 1998). MOMP 
is a glycosylated cysteine-rich protein with a molecular mass of 40 000Da (Newhall and 
Jones, 1983). MOMP is situated on the outer surface of the infectious EB, making it 
essential for the interaction between C.trachomatis and the mammalian host cell since the 
glycan moieties of MOMP is largely responsible for cell adhesion (Su et al, 1990). Other 
imperative functions of MOMP include the maintenance of the overall structure of the outer 
membrane, assisting in the formation of pores (Ortiz et al, 1996) and the regulation of 
nutrient and metabolite exchange for the RB (Bavoil et al, 1984). In addition, Ortiz et al, 
1996, demonstrated that human T-cells are activated by peptide epitopes that are found 
within MOMP, resulting in cell-mediated immunity.   
  
 2.3.2    Life Cycle and Development  
Chlamydia are obligate intracellular pathogens (Moulder, 1991). They replicate 
intracellularly within a membrane-bound structure called an “inclusion”, the membrane of 
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this inclusion, which originates as host cytoplasmic membrane, is altered by the insertion 
of chlamydial inclusion membrane proteins or Inc (Mital et al, 2010). These Incs play a 
role in the evasion of lysosomal fusion and degradation.   
The life cycle of chlamydia involves the adhesion and entrance of an infectious EB into a 
target cell (Elwell et al, 2016). Following entrance into the cell, the membrane bound 
chlamydia move along microtubules to the microtubule organising centre (MTOC). This 
movement is dynein-dependent but needs additional chlamydial proteins to move to the 
perinuclear region. Within 6-9 hours of entry, the EB swells (as the DNA becomes more 
diffuse) and ribosomes are synthesised, followed by the formation of the RB (Moulder, 
1991).   
Upon in vitro infection of cells with chlamydia, Yasir et al. 2011, noticed a substantial 
increase in the markers of autophagy. This is the intra-cellular degradation of nonfunctional 
organelles and is therefore a mechanism that can be used by the cell to remove chlamydia 
inclusions. Yasir et al. 2011 found that this defensive autophagy mechanism is activated if 
the chlamydial species is not adapted to the host, e.g C. muridarum in human cells. 
However, this defence mechanism was down regulated when the human parasite C. 
trachomatis, L2 was used.  
The RB body divides by binary fission, with a generation time of approximately 2-3 hours 
whilst the inclusion simultaneously intercepts sphingomyelin and cholesterol containing 
vesicles from the exocytic pathway with a preference for sphingomyelin (Hackstadt et al. 
1995, Moore et al, 2008). The subsequent reticulate bodies are reorganized into elementary 
bodies. Thereafter, these elementary bodies are released to infect other target cells  
(Moulder, 1991).   
The exit of C. trachomatis from host cells may take place by one of two methods: cell lysis 
or extrusion. The difference between the two is that the host cell dies during cell lysis while 
it survives during extrusion. Chlamydia induced cell lysis is a quick process facilitated by 
proteases (Hybiske & Stephens, 2007). The inclusion membrane ruptures and the cellular 
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organelles and cell membrane become permeable and lyse. In contrast, extrusion involves 
the exit of EBs from the host cell in an organised manner. Firstly, part of the membrane 
protrudes from the infected cell, resulting in the inclusion being snipped off into different 
compartments and substances attaching to the cell periphery. Thereafter (~2-3 hours), all 
chlamydial particles bound to the membrane are released. This process is advantageous to 
the bacteria since all particles remain protected from the extracellular environment for a 
short amount of time and are thereby protected from the host’s immune system (Hybiske 
& Stephens, 2007).   
Wyrick, 2000 made mention that mature chlamydial inclusions move along the 
exocytic/extrusive pathway to the surface of the epithelium to fuse with the plasma 
membrane. This happens at both, the apical membrane, allowing the release of chlamydia 
onto the epithelial surface and the basal membrane releasing chlamydia that disseminate 
within the tissue. In addition, leftover osmotically unstable RB are lysed in the extracellular 
milieu allowing only infectious EB to enter the infection cycle  
Under certain conditions, Chlamydia can establish a persistent growth state, where 
celldivision comes to a halt, resulting in cells becoming morphologically aberrant and 
capable of returning to a normal growth state after favourable host cell conditions are 
restored  
(Hackstadt et al. 1997).This phenomenon is known as “persistence” and takes place when 
there is a lack of nutrients and immunological attack (Wyrick, 2000). Only viable, 
noninfectious organisms (RBs) can become persistent whilst appearing enlarged and 
disintegrated during this state (Wyrick, 2000)  
  
2.4 Effect on the host cell  
As a typical feature of pathogenic gram negative bacteria, C. trachomatis uses a type 
III/contact-dependent secretion system (TTSS). The exact mechanism of this system remains 
unknown however, it is known that it plays an imperative role in the translocation of various 
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chlamydial antigens like MOMP, LPS and IncA. The system may also be involved in attaching 
to various hosts via injection of substances through host cells to mobilize the cytoskeleton thus 
orchestrating the intake of the bacterium (Wyrick, 2000).  
The inclusion membrane of C. trachomatis serves as the connection between the bacterium and 
the host. It disrupts the exocytic pathway, where sphingomyelin is integrated into the inclusion 
membrane, after being transferred from the trans-golgi thus becoming a component of the 
chlamydial cell wall (Hackstadt et al. 1995). Similarly, acquisition of cholesterol and 
phospholipids takes place. Changes to the inclusion membrane are made by Incs, which are 
inclusion proteins that have a hydrophobic domain that constitutes 40 amino acids.  
Surprisingly, there is no sequence homology to the hydrophobic domain found in the domain 
(Wylie et al. 1997; Bannantine et al. 2000).  
Field & Hackstadt, 2002 elucidated 5 InC proteins in the membrane of C. trachomatis 
inclusions, resulting in interactions with proteins of the host that allow for signal transduction.   
Interestingly, Fields & Hackstadt 2000 also found that inclusion membrane proteins that lack a 
hydrophobic domain also constitute part of InC proteins such as, CopN and CapL.  
Heizen & Hackstadt 1997 determined that the inclusion membrane remains impermeable to 
molecules sized 520D to 500kD however, Grieshaber et al. 2002 showed that the inclusion 
membrane may allow for the acquisition of cytoplasmic ions.   
It is known that iron is imperative for the growth of Chlamydia (Grieshaber et al. 2002) 
however, the means of acquisition of iron remain unknown. Nunez et al. 1990 have stated that 
endosomes, located close to the inclusion, contain the transferrin-transferrin receptor 
complexes and release Fe2+ after acidification and subsequent reduction. Given that the 
membrane is permeable by ions (Grieshaber et al. 2002), it is hypothesized that Fe2+ is 
transferred to the inclusion membrane via endosomes. Thereafter, they are released into the 
cytoplasm, allowing entrance into the Chlamydial inclusion via diffusion (Nunez et al. 1990). 
Once there is a substantial amount of organisms within the inclusion, the bacterium starts to 
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compete with the host for nutrients thus disrupting host cell replication (Horoschak & Moulder, 
1978).  
A cytotoxin in the EB of serovar D shares a substantial degree of homology with cytotoxins 
(LCT) A and B of Clostridium difficile (Belland et al. 2001). This cytotoxin interrupts the actin 
cytoskeleton and the intracellular interactions. Carlson et al. 2004 demonstrated that cells 
infected with a serovar D at an increased MOI caused the flattening of cells followed by actin 
depolymerisation. This was unlike cells infected with serovar L2, which maintain a constant 
morphology throughout.   
Cytotoxin CT166 displays a DXD motif imperative for the activity of enzymes, in both bacterial 
and mammalian type-A glycosyltransferases, expresses glycosyltransferase activity (Belland et 
al. 2001). In a study by Bothe et al. 2015, Hela cells that express the cytotoxin, were seen to 
also express the rounding of the cells, preventing the activity of Rho-GTPases Rac/Cdc42. 
Overall, this showed that CT166 has an imperative role in cellular functions, making it essential 
for the intracellular survival of chlamydia.  
In addition, Belland et al 2001, showed that the cytotoxin present in the EB is transferred to the 
host cell upon infection and has a virulent role, thus adding to the pathogenesis of the organism. 
Interestingly, Thalman et al. 2010 showed that the chlamydial uptake was disrupted in cells 
that over-expressed CT166, indicating that CT166’s role as an effector-protein during the 
infection of host cells may vary.  
  
  
  
2.5 Keratinocytes   
Human skin is a multi-layered epithelium with self-renewal and tissue repair capabilities 
(Figure 2.1). The epidermis, which is the outer-most layer of skin, forms a protective barrier on 
the surface of the body, consisting of stratified squamous epithelium and preventing the 
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entrance of pathogens (McGrath et al. 2004). The basal layer consists of proliferating cells 
which despite having a network of keratin intermediate filaments, are relatively 
undifferentiated (Alonso and Fuchs, 2003). As the basal cells begin to divide, a portion of these 
cells detach from the basement membrane and start to move outwards, towards the surface of 
the skin. Therefore, sloughed cells from the skin surface are continuously replaced by the basal 
cells that are moving towards the surface (Alonso and Fuchs, 2003).   
 
Figure 2.1: The various layers that make up the epithelium (Shier et al, 1999)  
2.5.1 Differentiation   
Keratinocytes, which constitute 90% of the epidermis, proliferate via mitosis in the basal layer 
(McGrath et al. 2004).  Daughter-cells undergo a change in composition during the different 
phases of differentiation, as they are pushed upwards towards the outermost layer of skin and 
eventually become anucleated. The phases of this differentiation are represented by the 
following: 1. The stratum basale, which is the germinal layer of the epidermis, where mitotic 
activity allows for a constant supply of new keratinocytes.  2. The stratum spinosum, which 
consists of cells that are undergoing growth and early synthesis of fibrilar proteins. 3. The 
stratum granulosum, containing intracellular granules that assist in keratinisation. 4. The 
stratum corneum, comprising flattened cells that have merged and consist of keratin (Pummi et 
al. 2001).   
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During the differentiation process, keratinocytes form desmosomes between each other as a 
result of their highly organized configuration. Keratin proteins and lipids are then secreted, 
which essentially allow for the protective strong exterior of skin (Elias, 1991).  
The proliferative and undifferentiated keratinocytes from neonatal as well as adult skin can be 
used for primary cell culture (Green, 1977). Differentiation of these keratinocytes may be 
stimulated by the addition of exogenous factors including chemicals such as calcium and Tissue 
Plasminogen Activator (TPA). Differentiation of keratinocytes can also be stimulated by 
inhibiting contact with the extracellular matrix,  by seeding them onto dermal equivalent 
substrates (DEDs) that are grown at the air-liquid interface, resulting in epidermal stratification 
(Lamb and Ambler. 2012).    
Although a number of studies have been conducted to develop serum-free, feeder-free media 
that support the growth and propagation of keratinocytes in 2-dimensional cell culture, the 
effect that these growth conditions have on keratinocyte stratification and differentiation into 
3-dimensional human epidermis remains unknown (Lamb et al. 2013). Our study only included 
Fetal Bovine Serum (FBS).   
  
2.5.2 Terminal differentiation  
During the process of proliferation, certain cells in the basal layer are released and begin the 
cycle of “terminal differentiation” instead. This phenomenon is orchestrated by the interaction 
between integrins and intracellular signalling pathways (Rippa et al, 2013). In addition, 
cadherins are receptors that allow for successful adhesion (Stanley et al. 1980) and the 
formation of junctions between cells (Tinkle et al, 2008).   
During terminal differentiation, β1 integrin activity is downregulated by decreasing the density 
of integrin receptors on the surface of the cell in combination with the inhibition of transcription 
of integrin genes and the prevention of immature integrin subunits from undergoing N-linked 
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glycosylation or being moved to the surface of the cell (Hotchin & Watt. 1992). 
(Yamamototanaka et al, 2014).  
Terminal differentiation remains possible in keratinocytes growing in media supplemented with 
little to no calcium, leading to involucrin expression, giving rise to the cornified envelope (Watt 
& Green. 1982). Furthermore, cell surface glycoproteins involved in lectin-binding are also 
expressed.  
In a study by Hodivala & Watt. 1994, it was seen that keratinocytes co-express both integrins 
and markers of terminal differentiation under conditions where culture medium is 
supplemented with a low concentration of calcium. When the concentration of calcium is 
increased, there is a significant reduction in integrins expressed in terminally differentiating  
cells.   
2.5.3 Adhesion  
Cell to cell adhesion of keratinocytes is controlled and maintained by various molecules packed 
into distinct structures the formation of which is regulated by the concentration of calcium ions 
(Rinnerthaler et al, 2015). Under a significantly low calcium concentration (30μm), 
keratinocytes only develop into a monolayer, lacking adherend junctions or desmosomes. In 
contrast, when the calcium concentration has been increased, desomosomes are formed, 
followed by the progression of stratification (Strudwick et al, 2015).   
Takeichi, 1988 has demonstrated that E-cadherin is involved in the formation of intercellular 
junctions.  Similarly, Mertz et al, 2013, demonstrated that cadherin-based cell-cell adhesions 
has an integral role in orchestrating the physical activity of epithelial cells since naïve mouse 
keratinocytes without cadherin-based adhesions displayed traction forces that extended 
throughout the respective colony whereas those with cadherin-based adhesions were able to 
localize traction forces to the periphery of the colony. This was indicative that cadherin-based 
adhesions are essential for this mechanical action of keratinocytes.  
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Desmosomes, which are cell-cell adhesions coupled to the intermediate filament cytoskeleton, 
are not only essential for the mechanical activity of the cells but are also remodelled to maintain 
homeostasis of epithelial cells (Osmani and Labousse, 2015).  
In a study by Wheelock & Jensen. 1992, interactions shared by E cadherin, P cadherin,  
Vinculin, β1 integrin and desmoplakin were examined, during the development of intercellular 
junctions and stratification. All markers began concentrating at the cell to cell borders when the 
calcium concentration was increased.   
 2.5.3.1 Cadherins    
The most commonly expressed cadherins on keratinocytes are P-cadherin, E-cadherin, 
desmocollin and desmoglein (Caldwell et al, 2016).  
Van Roy 2014 stated that E-cadherin is expressed in all of the cell layers, but Pcadherin 
is only expressed in the basal layer, in both in-vivo and in-vitro epidermis.  
The binding of cadherins is a homophillic process and is dependent on calcium, seeing 
that intercellular adhesion is prevented upon the reduction of calcium ions in culture 
medium during in vitro stratification (Strudwick et al, 2015). This subsequently 
prevents keratinocytes from stratifying. Cadherin expression occurs simultaneously 
with the assembly of desmosomes and adherence junctions when the culture medium 
has a concentration of ~1.8mM calcium followed by the migration of terminally 
differentiating keratinocytes to the suprabasal layer from the basal layer (Hennings &  
Holbrock, 1983).   
Interestingly, antibodies to E-Cadherin cause a fractional inhibition of stratification. 
However, this is not the case with antibodies to integrins (Larjava et al. 1990).   
As specified in a study by Hodivala & Watt. 1994, a significant loss in integrins is seen 
in terminally differentiating cells in medium with reduced calcium. This was also seen 
due to antibodies to P and E cadherin, which prevented stratification, indicating that 
cadherins downregulate the expression of integrins in keratinocytes. The reason as to 
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why cadherins allow for the loss of integrins may be because of the competition of the 
two molecules for a cytoskeletal molecule required for expression in different 
keratinocytes (Hodivala & Watt. 1994). Since antibodies inhibit integrin mRNA 
reduction, it can be assumed that this took place at the integrin gene transcription level  
(Hotchjin & Watt, 1992). This study was in accordance with Wheelock and Jensen.  
1992, which reported the inhibition of calcium-assisted stratification by antibodies to 
E-cadherin and P-cadherin. Furthermore, this study also pointed out that although 
stratification was substantially reduced in the presence of anti-E Cadherin, there were 
a few vertical layers that were still formed by the keratinocytes, but they lacked 
adhesive properties. On the other hand, cells still expressed filaggrin, which is a marker 
of differentiation. Cells also collected an overload of desmoplanktin at the cell-cell 
connection, correlating to that of normally stratified in vitro keratinocytes.  
Interestingly, although stratification and integrin expression were both reduced upon 
the addition of antibodies to cadherin, desmosomes were still seen between the cells 
within the subsequent monolayer, indicating that desmosome-formation occurs 
regardless of the reduction of integrins and vice versa (Hodivala & Watt. 1994).   
  
2.5.4 Stratification  
It is possible for naïve keratinocytes to be isolated from the human epidermis and cultured in 
vitro to allow for differentiation and subsequent stratification (Chavez-Munoz et al, 2013). This 
may be done upon the addition of calcium, TPA, limiting the attachment of the keratinocyte 
extracellular matrix via a forced cell suspension, or by growing keratinocytes onto dermal 
equivalents at the air-liquid interface, resulting in stratification (Green. 1977) (Lamb & Ambler, 
2013).   
Prunieras et al. 1983 stated that growing primary keratinocytes at the air-liquid interface on 
dermal equivalents, such as de-epidermalized de-vitalized human skin (DEDs), generated a 
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structure that closely resembles in vivo skin. This may be due to the fact that DEDs retain the 
extracellular matrix proteins and the original structure of the normal human dermis, resulting 
in stratified structures of keratinocytes with the same layers present in in vivo skin, namely; the 
basal, spinous, granular and corneum layers. The results of this are concurrent with a study 
conducted by Lamb & Ambler 2013, who also made use of DEDs to generate a stratified 
keratinocyte structure.  
In vitro methods for propagating primary keratinocytes were developed by James Rheinwald 
& Howard Green. Briefly, human keratinocytes were seeded onto irradiated J2-3T3 fibroblasts 
in media consisting of various supplements such as insulin, hydrocortisone, cholera toxin and 
epidermal growth factor (Rheinwald et al. 1975). Recent studies still use the aforementioned 
techniques, with slight modifications. However, to prevent detrimental consequences such as 
bovine spongio-encelopathy and infections with mouse viruses, methods using serum-free, 
feeder-free conditions were established (Coolen et al. 2007).  
Bullock et al. 2006 described methods developed in the laboratory of Sheila MacNeil, using 
serum-free media and human fibroblasts, as opposed to murine feeder-cells. As a result, various 
commercial companies have also headed in the direction of supplying serum-free, feeder-free 
media that allows for the propagation of keratinocytes in a 2D cell culture environment. Despite 
successful propagation, the capacity of these keratinocytes to properly stratify under these 
conditions are limited. The reasons for this are so far unknown.  
Lamb & Ambler (2013) used two different serum-free, feeder-free culture media, both of which 
were successful in providing a suitable in vitro environment for primary keratinocyte 
propagation but these keratinocytes were unable to stratify and develop into a model 
comparable to in vivo skin. Surprisingly, this was not due to a reduced calcium concentration 
in the media since the increase thereof did not result in an increased capacity of keratinocyte 
stratification. Upon the addition of 10% Fetal-Bovine Serum (FBS) and calcium to the 
supplement-free media, keratinocytes began to successfully stratify. Thus, Lamb & Ambler 
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2013 proved that keratinocytes have the potential to stratify in an in vitro provided that they are 
grown in media supplemented with factors that are biologically active.   
Commercially available keratinocytes have various properties that may alter their capacity to 
stratify and undergo reconstruction. These factors include the passage of the cell type, 
differences in the methods of isolating the cells, contamination of cell types, differences in the 
ages of the donor and the body-sites from which the keratinocytes were isolated. Furthermore, 
keratinocytes which have been passaged more than 3 times have a below-optimum ability to 
stratify (Gilchrest et al. 1983). HaCaTs are capable of being passaged a number of times after 
the original (Fusenig & Boukamp, 1998).  
  
2.5.5. Keratins   
Keratins make up part of the family of intermediate filamentous proteins found specifically in epithelia 
formed by keratinocytes (Salas et al, 2016). Approximately 30 proteins polymerize into filaments 
measuring up to 10nm in size, therein lacking auxiliary proteins (; Hatzfeld et al., 1990; Steinert, 1990). 
Type I keratins are comprised of K9-K20, whereas type II consists of K1-K8. The amino acid sequence 
is found in an α-helical structure upon the central rod domain of the polypeptides (Coulombe & Fuchs, 
1990; Coulombe et al., 1990).  
Filament assembly is a process whereby a type-I keratin and a type-II keratin assemble, forming a 
parallel heterodimer. Thereafter, the rod domains form a coil that subsequently connects with various 
dimers, resulting in tetramers allowing for the production of protofilaments and eventually, mature 
filaments (Hermann et al, 2009). In most cases, especially in epithelial tissue specific to a certain 
differentiation pathway, keratins are seen in particular pairs even though the identity of the type-I keratin 
forming heterotypic combinations with type-II, in vitro, is generally irrelevant in the formation of 
filaments in fibroblasts. (Moll et al. 1982. Banerjee et al, 2014). K5 and K14 are always found in the 
basal layer, which is mitotically active (Williams et al, 2014) and make their way via the cell cycle to 
the suprabasal compartment (Fuchs. 1993).  
19  
  
2.5.5.1 The effect of differentiation on keratins   
Most often, differentiation in keratinocytes is irrevocable, allowing for a drastic change in the 
cytoarchitecture and the subsequent flattening of keratinocytes (Wierzbicka et al, 2017). 
Furthermore, the keratinocytes become prone to losing various organelles and their nuclei alike 
(Anderson et al, 2014). The keratins, on the other hand, remain cross-linked to a cornified 
envelope, consists of keratins inside an insoluble mixture of proteins that are cross-linked by 
transglutaminases and enclosed by a lipid envelope (Reichert et al. 1993. Simon. 1994. Eckert 
et al. 1997. Candi et al. 2005). Such changes are followed by the subsequent switch in the 
expression of keratins, whereby K5/K14 gene expression becomes downregulated in 
keratinocytes that migrate out of the basal stratum to the surface (Williams et al, 2014). The 
expression of genes coding for a different keratin pair varies in different types of stratified 
epithelia (Morgan et al. 1987).  
Characteristically, K1/K10 are expressed in the cornified epithelium but K4/K13 is expressed 
in non cornified epithelia (Danielsson et al, 2014). K3/K12 expression is induced in the cornea 
(Quinlan et al. 1985), whereas K6/K16 expression is detected in the outer root sheath of hair 
follicles. Interestingly, keratin 15 (Type I) lacks a type-II keratin.  (Stark et al. 1987. Heid et 
al.1988).  
Leube et al. 1988 found that the mRNA of K15 is seen in all layers of stratified epithelium, 
using radioactive in situ hybridization. Essentially, this study, together with various others, 
implied that K15 is expressed in the basal layer and the expression thereof, will continue, 
regardless of the upward differentiation of migrating keratinocytes.  
Contrastingly, Lloyd et al. (1995) demonstrated that K15 is absent in cells in the suprabasal 
layers and is found only in basal keratinocytes instead.  
  
2.6. HaCaT cells   
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The HaCaT cell line is an immortalized keratinocyte cell line isolated from adult human skin by 
Boukamp and colleagues in 1988 (Boukamp et al. 1988). The cell line was originally isolated from a 
healthy skin specimen of male body from the melanoma and the name “HaCaT” is derived from  
“Human Adult keratinocytes propagated under low Calcium conditions and elevated Temperatures” 
(Boukamp et al. 1988).  
The capacity of this cell line to differentiate and stratify has been widely investigated and it was found 
to express the majority of the markers for differentiation (Fusenig & Boukamp 1988). The cell line lacks 
tissue organisation when grown in organotypic co-cultures with fibroblasts, however, MaasSzabowski 
et al. (2003) demonstrate that the organization may be restored when the media is supplemented with 
epidermal growth factor.   
  
2.7. Fibroblasts   
Fibroblasts are the prominent cell type seen in the connective tissue of vertebrates, expressing the 
capacity to synthesize the extracellular connective tissue matrix. Fibrocytes are the metabolically 
inactive forms of fibroblasts and they play little to no role in the maintenance of the extracellular matrix 
and tissue (Weissmanhomer et al. 1975)  
The physical appearance of fibroblasts is dependent on the site from which they were isolated and their 
respective function and activity. Fibroblasts may retain this function over a number of generations 
causing them to sometimes stagnate (Weissmanhomer et al. 1975).  
Fibroblasts are identified by their branched cytoplasm, which encloses a nucleus. Metabolically-active 
fibroblasts have a substantially large amount of rough endoplasmic reticulum. Active fibroblasts are 
spindle-shaped with much fewer endoplasmic reticula. Over a wide surface area. Fibroblasts are 
incoherent, but become locally aligned in parallel clusters when confluence is reached (Dave & Bayless, 
2014).  
21  
  
Fibroblasts have the capacity to synthesize a number of components vital for the structure and 
maintenance of the extracellular matrix, namely; collagens, glycosaminoglycans, reticular and elastic 
fibers and glycoproteins (Weissmanhomer et al. 1975).   
  
2.8. Stromal interactions  
An interaction between the neighbouring cells and the extracellular components of the neighbouring 
stroma are vital for the replenishment and restoration of epithelial tissue. A demonstration of such is 
seen in studies regarding wound-repair and transplants which support observations that tissue repair and 
replenishment is dependent on the action of cytokines and growth factors (Luger & Schwarz. 1990).  
Similarly, Rheinwald & Green 1975, showed that the proliferation and differentiation of keratinocytes, 
in vitro, can be induced and supported by stromal cell interactions. This concept is used in 2D feeder 
layer organotypic co-cultures with post-mitotic fibroblasts.  
It is important to note that the proliferation of keratinocytes in such cases is not only supported by the 
influx of growth factors provided by the fibroblasts, but rather by the continuous interaction between 
both cell lines in a double paracrine mechanism (Maas-Szabowski et al. 2001). This allows for 
keratinocytes to maintain the production of growth factors in fibroblasts by the secretion of interleukin- 
1 (IL-1) α and β, which in turn, induce the expression of keratinocyte growth factor/fibroblast growth 
factor 7 (KGF/Fgf-7) and granulocyte macrophage colony-stimulating factor (GM-CSF). These growth 
factors allow for the proliferation of keratinocytes and their expression thereof is increased during 
wound repair (Maas-Szabowski et al. 2000)  
Maas-Szabowski et al. 2000 proved that the double paracrine mechanism between the two cell types 
allows for the release of IL-1 by keratinocytes and KGF/FGF-7 and GM-CSF produced by fibroblasts, 
thus inducing differentiation and stratification of keratinocytes when using post-mitotic fibroblasts as a 
feeder layer in organo-typic co-cultures of the two cell types. The study demonstrated that these 
molecules constitute part of the epithelial-stromal interactions that induce and maintain tissue-repair. 
The study also corroborated that both growth factors are not functional in the absence of stromal cells.  
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Maas-Szabowski & Fusenig (1996) showed that it is especially advantageous to use post-mitotic 
fibroblasts as opposed to naïve fibroblasts as it will eliminate the proliferative action of fibroblasts in 
the co-culture, thus omitting inconsistent stromal cell numbers. Fibroblasts may become post-mitotic 
when exposed to γ-irradiation.  
In contrast, Blanton et al 1991 stated that human keratinocytes involved in organotypic co-cultures did 
not stratify and differentiate which is in keeping with studies by Durst et al. 1989, Oda et al. 1996 and 
Tsuenenganga et al. 1994. However, a substantial number of later studies looking into stratification, 
indicate that immortalized human keratinocytes have a high capacity for stratification (Boukamp et al. 
1998).  
Organotypic co-cultures comprising of HaCaT cells and fibroblasts display minimum differentiation 
and stratification and suffer abnormal structure and keratinization (Haake & Polakowska. 1993). 
Comparably, HaCaT cells have the capacity to form stratified, differentiated structures, taking a much 
longer time to do so as opposed to normal keratinocytes. This delay is primarily due to the decreased 
secretion of IL-1 in HaCaT cells, resulting in a reduced expression of growth factors, KGF and GMCSF. 
Furthermore, the receptors of both growth factors experience a substantial decrease in expression 
resulting in the loss of signal transduction. In addition, in HaCaT cells there is a reduced release of the 
keratin growth factor, TGF-α. Thus, by adding TGF-α, HaCaT cells may regain the ability to stratify 
and differentiate. In addition, there is also a simultaneous increase in IL-1and the subsequent increase 
in KGF and GM-CSF, subsequently resulting in a functional interaction with stromal cells in effort to 
generate a stratified skin model from HaCaT cells comparable to normal keratinocytes (Maas- 
Szabowski et al. 2003).  
  
CHAPTER 3 – MATERIALS & METHODS  
  
3.1. Cell culture  
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3.1.1. Cell lines   
For the propagation of C. trachomatis, the McCoy cell line (ATCC® number CRL – 1696) was used. 
This is an immortalised, adherent mouse fibroblast cell line, commonly used for the propagation of 
chlamydia.   
A spontaneously immortalized human keratinocyte cell line, known as the HaCaT cell line, was used 
for the generation of the stratified keratinocyte model. The cell line was donated by Professor Norbet 
E. Fusenig of the Cancer Research Centre, Heidelberg, Germany).  
  
3.1.2. Cell Culture Media   
3.1.2.1. McCoy cells  
For the McCoy cell line, Eagle’s Minimum Essential Medium (EMEM) (BioWhittaker™, Walkersville, 
USA) supplemented with Earle’s Balanced Salt Solution (EBSS), HEPES (25mM) (BioWhittaker™, 
Walkersville, USA) and L-glutamine (2mM) (BioWhittaker™, Walkersville, USA) was used. HEPES  
buffer assists in maintaining the pH at 7.4. Glutamine, is separately added to the media since it breaks 
down faster in complete media compared to other amino acids (ATCC technical information).  
3.1.2.2. HaCaT cells   
HaCaT cells are a spontaneously immortalized human adult skin keratinocyte cell line developed by  
Boukamp and team in 1988 (Boukamp et al. 1988). This cell line has been nontumerogenic for over 
300 passages, which spans over 6 years in culture (Boukamp et al. 1994). The cell line is capable of 
expressing all epidermal differentiation markers, even though it undergoes various chromosomal 
changes whilst adapting to autonomous growth in vitro (Boukamp et al. 1988). When grown in 
organotypic cocultures with fibroblasts, HaCaT cells display little to no tissue organization, however, 
this is restored when supplemented with epidermal growth factor (Boukamp et al. 1998).  
The cell line is widely studied in cell-cycle research (Chaturvedi et al. 1999), carcinogenesis (Boukamp 
et al. 1994) and they are susceptible to apoptosis (Lee et al. 2005).   
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For this study, HaCaT cells were propagated in Hyclone Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with HEPES (10mM) and used as a result of lab-availability. Sterile 
heatinactivated fetal bovine serum (FBS) (Gibco™, Scientific group) was added to the media to provide 
various cytokines and growth factors required for the regulation of cell propagation, growth and 
differentiation.   
For the development of the stratified keratinocyte model, HaCaT cells were grown in Hyclone DMEM 
supplemented with both, 10% FBS and 1.4 mM CaCl2.   
Upon confluency, cells were exposed to the air-liquid interface, where FBS and CaCl2 supplemented 
KGM-Gold™ Keratinocyte Growth Medium with Bulletkit™ (Lonza) was added to the bottom 
chamber. Bullet kit™ contains hydrocortisone (0.5ml), bovine pituitary extract (BPE) (2ml), human 
recombination epidermal growth factor (rhEGF) (0.5ml), transferrin (0.5ml), epinephrine (0.25ml), GA-
1000 (0.5ml) and insulin (0.5ml).  
Incubation of cultures for all experiments were carried out in an incubator with 5% CO2 in 95% air, 
either at 33°C or 37°C.   
  
3.1.3. Cultivation and revival  
Cells suspended in storage media in cryovials were kept at -70°C for short term storage or at -96°C for 
long term storage. When required, cells were thawed by placing the cryovial in a beaker with water at 
37°C. Thereafter, the cryovial was gently swirled, the outside swabbed with 70% ethanol and moved 
into a class II biosafety cabinet where cells were seeded in a 75 cm2 tissue culture flask with the 
appropriate cell culture medium with a temperature of 37°C. Thereafter, the flask was incubated at 37°C 
with 5% CO2.  
To observe confluency of the cells and to determine possible contamination or cell deterioration, cells 
were viewed with an inverted microscope every day.  
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Media was changed every other day, where spent media was discarded and cells were washed 3 times 
with phosphate buffered saline (PBS)  (Dulbecco A Oxoid) with Ca2+ or Mg2+ pH 7.2 to eliminate 
residual FBS and cells that were not attached. Thereafter, fresh cell culture media, supplemented with 
10% FBS, was added to the flask, followed by reincubation.   
Subculturing was conducted when the monolayer reached 90% confluency. Cells were seeded into new 
culture flasks to maintain stock, in 24-well plates for experiments or in cryovials for storage. The 
subculturing technique remains the same for all cell lines, except for HaCaT cells, which need one extra 
step. After washing the keratinocyte monolayer 3 times with PBS, pH 7.4, 2ml 0.05 
ethylenediaminetetra-acetic acid (EDTA) solution (Sigma, Steinhein, Germany) is added to the flask 
and incubated for 5-10 minutes at 37°C. Once intracellular spaces were microscopically detected, 
EDTA was removed.   
After this step, the procedure remains standardized for all cell lines. One ml 0.05% trypsin – 0.02%  
Versene (EDTA) solution (BioWhittaker ™) in PBS, pH 7.4. is added. The flask is then gently swirled, 
ensuring total coverage of the surface area of the flask. After incubation for 1 minute at 37°C, the flask 
is gently tapped to assist detaching of the cells. Thereafter, 1ml undiluted FBS is added to the flask to 
neutralize the trypsin. This was done with a Pasteur pipette, by squirting FBS against the back of the 
flask, thus removing detached cells. The cell suspension was decanted to be seeded or cryopreserved.  
For cryopreservation, cell suspensions with an equal volume of storage fluid (Appendix), which was 
added drop by drop to the suspension, was aliquotted into the cryovials and sealed with parafilm. The 
name of the cell–line, storage date, passage number and the cell concentration was recorded on each 
cryovial.   
  
3.1.4. Determining the cell numbers   
In order to deduce the number of viable and non-viable cells, the Trypan Blue Dye Exclusion Assay 
was conducted, using a Neubauer haemocytometer.  
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Once it was wiped with 70% ethanol, the haemocytometer was covered with a square coverslip and 20 
μl cell suspension was added to 20 μl 0.4% trypan blue solution (Sigma) and thoroughly mixed. A drop 
of the mixture was then placed at the edge of the coverslip, where it was drawn in to fill the counting 
chamber. Viable and dead cells are easily differentiated when viewing under a light microscope, since 
trypan blue remains in dead cells and is excluded from viable cells, allowing dead cells to appear blue 
and viable cells colourless. The number of clear and blue cells were counted in the 5 primary squares 
(Maleka et al. 1996). Clumped cells were counted as though they were separate individual cells. If too 
many clumps were seen, the suspension was mixed again and the procedure was repeated. Since the 
volume of each primary square is 1X10-4ml, the following formula was used to calculate the 
concentration of cells per ml:  
Concentration = 𝑁/5 X 104 X dilution factor  
Where 𝑁= total number of cells in the 5 primary squares.  
The total cell number was calculated by the following:  
Total cell number = concentration (cells/ml) X total volume (ml)  
  
The percentage cell viability was calculated as follows:  
% cell viability = (Number of viable cells) / (Total number of cells) X 100  
On the occasion that the number of cells in each primary square was too many to count, the cell 
suspension was diluted with PBS and the Trypan Blue Exclusion Assay was repeated.  
  
3.2. Bacterial culture  
Chlamydia trachomatis L2 strain 434 (ATCC® number VR-902B™) was used for this study. This strain 
was originally isolated from a bubonic aspirate of a military service man returning from Asia who 
presented with typical LGV symptoms (Schachter et al. 1969).  
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3.2.1. Propagation and storage of C.trachomatis  
McCoy cells were cultured in 75cm2 tissue culture flasks and passaged according to the procedure 
described above. The cell cultures were incubated at 37°C with 5% CO2 until the monolayer of cells 
reached 80-90% confluency. Confluency and possible potential contamination was assessed by viewing 
the cells on a daily basis with an inverted microscope. Media was changed every second day.  
When the desired confluency was reached, spent media was aspirated from the flask. Thereafter, the 
monolayer was washed three times with PBS. Twenty μl Chlamydia Growth Medium for propagation  
(CGM-P) was added to the flask. CGM-P consists of EMEM (BioWhittaker™) with Earle’s Balanced 
Salt Solution (EBSS)  (Gibco®), non-esseential amino acids (NEAA) and sodium pyruvate, 
supplemented with 10mM HEPES, 2mM L-glutamine, 1μg/ml cycloheximide, 5.4 mg/ml glucose, and 
10% FBS. In addition, gentamicin (10μg/ml), and amphotericin B (5μg/ml) were added.  
Chlamydial elementary bodies suspended in 100 μl sucrose-phosphate buffer (SPG) were added to the 
flask. A flask to which 100 μl SPG without chlamydia was added served as the negative control. Flasks 
were centrifuged for 1 hour at 1200g at room temperature in a temperature controlled centrifuge and 
incubated for a further hour at 37°C. A media change with CGM-P supplemented with 10% FBS was 
then conducted to remove any dead and unattached cells.  The flasks were incubated at 37°C for 48 
hours.    
  
  
  
3.2.2. Propagation of chlamydia  
After 48 hours, the cultures were viewed with the inverted microscope to detect chlamydial inclusions. 
CGM-P media was removed from the flasks and the monolayers were washed with PBS. SPG 
supplemented with 10% FBS was added as well as sterile glass beads.  The flasks were vortexed to 
disrupt the McCoy cell monolayer, thus releasing chlamydial EBs. The cell lysate containing chlamydial 
EBs was transferred to a clean centrifuge tube.  Cell debris was pelleted by centrifugation at 1000 x g 
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for 10 minutes at 4°C.  The supernatant containing the chlamydial EBs was transferred to a clean 
centrifuge tube, aliquoted and frozen at -80°C.  The pellet containing cell debris was discarded.  
  
3.2.3. Determination of the infectious titre  
Serial 10-fold dilutions of the C. trachomatis isolate were prepared and used to inoculate McCoy cells 
grown in a 96-well microtitre plate to 80% confluency. Cells were centrifuged at 1200 x g for 1 hour at 
room temperature and incubated at 37°C for 1 hour. Spent media was removed and replaced with fresh 
CGM, followed by further incubation at 37°C in 5% CO2. After incubating for 48 hours, infection of 
the monolayers was confirmed using the MicroTrak® C. trachomatis Culture Confirmation Test Kit.   
This kit involves contains monoclonal antibodies against an antigenic determinant of the major outer 
membrane protein (MOMP) found in the outer membrane of all known serovars of C. trachomatis. 
These antibodies are labelled with FITC. C. trachomatis-positive cultures will be identified by the 
presence of green fluorescing intracellular chlamydial inclusions, against a background of red cells due 
to the Evans Blue counterstain.  Assuming that each inclusion body evolves from one EB, the number 
of inclusions can be enumerated per field of view, allowing for the determination of the infectious titre.  
The required calculation for determining the infectious titre is as follows:  
Conc. (CFU/ml) = (# of inclusions/n) x (100ul/V) x (C x D) Where:  
• n = # of fields counted  
• V = Volume of the inoculum (ml)  
• C = Objective lens conversion factor  
• D = Dilution factor (ml)  
  
  
3.3. Preparation of a stratified keratinocyte model   
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A vial of stored HaCaT cells was revived as per 3.1.3. Once the cells were 80% confluent, they were 
trypsinised and seeded into 24 well plates, in which polytetrafluoroethylene (PTFE) membrane inserts 
(Pore size 3um) (Costar) had been placed. Cells were seeded at a cell density of 1x106 cells/ml.  
A volume of 600μl cell culture medium (Hyclone DMEM) supplemented with 10% FBS was added at 
the bottom chamber, whereas 100 μl cell suspension in culture medium (Hyclone DMEM) 
supplemented with 10% FBS added to the upper chamber. Cells were then incubated at 37°C with 5% 
CO2 and a media change was conducted every second day.   
Upon confluency, cells were exposed to the air-liquid interface by replacing medium in the bottom 
chamber with KGM-Gold media prepared according to the manufacturer’s instructions. This medium 
was supplemented with 10% FBS and the CaCl2 concentration was raised from 0.1mM to 1.4 mM to 
facilitate stratification and differentiation (Lamb and Ambler, 2013).   
Thereafter, inserts were incubated at either 33°C or 37°C for 2 weeks and 3.5 weeks.   
Controls were also prepared as outlined above. These cells were not exposed to the air-liquid interface 
and were incubated for 1 week and at both temperatures.   
  
3.4. Infection of the stratified keratinocyte model with C. trachomatis  
Spent media was discarded and fresh CGM-P was added to all wells. The volume of fresh media added 
was 600 μl to the bottom chamber, and 50 μl to the upper chamber. C. trachomatis L2 elementary bodies 
(infectious titre: 1.5x109 cells/ml) were prepared in SPG with FBS to a concentration of 4x107 EB/ml.   
Fifty μl of the EB suspension in SPG-FBS was added to the upper chamber and the plates were incubated 
at 33°C and 37°C respectively for 3 hours. Thereafter, media was removed from the upper chambers 
followed by incubation at their respective temperatures for a further week to allow for penetration to 
the underlying layers.  
Cycloheximide was omitted from the medium, since it would negatively affect eukaryotic cell 
replication, thus preventing an in vivo-like environment (Elela et al. 1997).  
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Control wells seeded with 50 μl SPG with FBS in the upper chamber instead of chlamydia suspension 
were incubated at both 33°C and 37°C.   
  
3.5. Histology  
Various histology techniques were used to compare whether or not a stratified layer of keratinocytes 
was formed and how closely the in vitro system mimicked human skin in vivo. Histological observations 
were used to select the temperature and duration of incubation that allowed keratinocytes to differentiate 
and most closely approximate the structure of the in vivo epidermis for use in future experiments.  
Once the system was optimised, the cells were infected with C. trachomatis and stained with the 
MicroTrak ® C. trachomatis Culture Confirmation Test Kit to confirm infection and track the migration  
of C. trachomatis through the layers.  Hematoxylin and Eosin (H&E) staining and  
immunohistochemistry was performed on infected cell cultures to detected structural changes.  
For histology, cells were fixed, embedded in a paraffin block, cut in thin sections, stained and visualised 
using an appropriate microscope.  
  
3.5.1. Preparation of Costar ® Transwell ® Inserts for histology  
In order to prepare the Transwell inserts for histology, a protocol by Corning Incorporated (Corning  
New York) was used.  The procedure was carried out with minor modifications as follows:   
Transwell membranes were rinsed with Hank’s Buffered Saline Solution (HBSS) (37°C). The HBSS 
was added slowly and aspirated carefully thereafter so that neither surface of the membrane was 
touched. The membrane is extremely delicate therefore it was of utmost importance that it was handled 
with care, to prevent shredding or tearing. The rinse procedure was repeated.  
Thereafter, 10 % phosphate buffered formalin (pH 7.4) brought at room temperature was added to the 
wells and membrane inserts. The plate was then left in the biosafety cabinet at room temperature to 
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allow for fixation. After 1 hour, the membrane inserts were rinsed with HBSS (37°C). The inserts were 
then dehydrated by replacing the HBSS with ethanol in a graded series of concentration, as follows:  
35% ethanol for 10 minutes; 50% ethanol for 10 minutes; 70% ethanol for 10 minutes; 95% ethanol for 
10 minutes; 100% ethanol for 10 minutes and 100% ethanol for 10 minutes.  
The 100% ethanol was then replaced with Isopropanol. The isopropanol was left to infiltrate the cells 
and membranes for 10 minutes and this step was repeated. Once the isopropanol was removed from the 
wells and membrane inserts, liquid paraffin (58°C) was added. The plate was then placed in an oven 
(58°C) for 1 hour. Thereafter, the paraffin was changed and left in the oven for a further hour. The plate 
was then removed from the oven and the paraffin was allowed to solidify. By warming the outside of 
the plate, the inserts were removed whilst still containing solid paraffin on the inside of the inserts.   
For each step of this procedure, the volume of the reagent added to the wells remained standardized:  
600 μl at the bottom chamber and 100 μl at the upper chamber.   
Using a small scalpel blade that had been wiped with 70% ethanol, the membrane (with attached 
paraffin) was cut from the insert. The paraffin embedded membrane was then placed into a paraffin 
boat. The plug was held in a vertical, upright position using a clean pair of forceps whilst the paraffin 
was poured over it. This orientation allowed for a cross section view of the cells after sectioning.   
Thin sections of 8 μm of the paraffin-embedded membrane were cut according to standard histology 
procedure using a microtome. The sections were mounted on glass slides and left to dry.  
  
  
3.5.2. Hematoxylin and Eosin staining  
H&E staining was used to determine the resemblance of the stratified keratinocytes to in vivo human 
skin. This staining technique was also used after infection with C. trachomatis (see below), in addition 
to the MicroTrak ® C. trachomatis Culture Confirmation Test Kit. The haematoxylin stains the nuclei 
of cells, causing them to appear a distinct shade of blue. The counterstaining with a solution of eosin Y 
(alcoholic or aqueous) causes other eosophilic structures to appear red, pink or orange.  
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H & E staining was performed as follows using the method described by Luna (1960):  
Thin sections were deparaffinised. This was done using a series of decreasing concentration of ethanol. 
Slides were dipped in 100% ethanol followed by 90% ethanol, 70% ethanol, 50% ethanol, 30% ethanol 
and distilled water. Mercuric chloride crystals were removed by dipping slides in iodine. Slides were 
then flooded with Mayers hematoxylin for 15 minutes. Thereafter, they were washed with running tap 
water for 20 minutes and counterstained with eosin for 1 minute. Lastly, the thin sections were 
dehydrated in 95% and 100% alcohol, in order to remove the excess eosin. The sections were then 
visualised using a bright field microscope.  
  
  
3.5.3. Immunofluorescence   
Immunofluorescence was used to determine whether or not the keratinocytes had differentiated.   Mouse 
derived primary antibodies against keratin 10, keratin 14 and involucrin were used.  A goat anti-mouse 
secondary antibody conjugated to fluorescein isothiocyanate (FITC) was used to facilitate detection. 
The antibodies were purchased from Santa Cruz Biotechnology, Inc. (Dallas, Texas, U.S.A).    
After staining, thin sections were mounted using Prolong Gold anti-fade with DAPI and viewed and 
photographed using the Evos™ FL Cell Imaging System with appropriate filters.  
The protocol for immunofluorescence staining was carried out according to the manufacturer’s 
instructions with minor optimizing modifications. The procedure was conducted as follows:   
Thin sections were deparaffinised in xylene. Although the protocol suggests three changes for five 
minutes each, the slides were dipped in xylene once for approximately 30 seconds only. This was done 
because the 3 x 5 minutes were too harsh on the sections as they were being washed away during the  
trial run.   
The sections were then hydrated gradually through graded alcohol. The original protocol suggested 
washing in 100% ethanol twice for 10 minutes each, then 95% ethanol twice for 10 minutes each and 
finally washing in deionized water for 1 minute with stirring. However, since this was also found to be 
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too harsh during the trial run, the slides were only dipped in the respective concentrations of alcohol for 
approximately 30 seconds each.  
Antigen unmasking was then conducted by placing the slides in a container with enough 10mM Sodium 
Citrate Buffer, pH 3.5 with 0.01% (w/v) EDTA to cover the slides. The container was then placed in a 
water bath at 95°C for 5 minutes. It was then topped off with fresh buffer and left in the water bath for 
an additional 5 minutes. Slides were then allowed to cool in the buffer for 20 minutes and washed in 
deionized water three times for two minutes each. Excess liquid was then aspirated from the slides.   
Slides were then incubated at room temperature with blocking serum (10% goat serum in PBS) for 20 
minutes. This allows for the suppression of non-specific binding of secondary antibodies. Blocking 
serum is derived from the same species in which the secondary antibody is raised. After 20 minutes, the 
slides were washed with PBS.  
A 1:50 dilution was chosen for each primary antibody (200 μg/ml) in PBS with 0.15% blocking serum. 
The slides were then incubated with the diluted primary antibody (4μl/ml) for 60 minutes at room 
temperature. Thereafter, slides were washed three times with PBS.   
The slides were then incubated for 45 minutes in a dark chamber with FITC-conjugated secondary 
antibody diluted in PBS with 1.5% blocking serum. Thereafter, slides were washed three times with  
PBS. This step needed optimisation which is discussed in chapter 4.  
To confirm that non-specific binding of the secondary antibodies had not occurred, slides with cells 
incubated at either 33°C or 37°C were prepared as per the procedure outlined above whilst omitting the 
step involving incubation with the primary antibody.  
Coverslips were then mounted onto the slides using Prolong Gold Antifade with DAPI and viewed with 
the Evos™ FL Cell Imaging System and appropriate filters.  
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CHAPTER 4 – RESULTS   
  
4.1 Optimisation of methodology   
The methodology applied in our experiments is based on publications on similar work with 
keratinocytes. Some aspects had to be optimized for working with HaCaT cells.  This included the 
duration of incubation, the working dilutions of primary and secondary antibodies used for 
immunofluorescence tests and keratinocyte-fibroblast organotypic co-cultures.  
  
4.1.1 Duration of incubation   
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In order to determine which duration of incubation at both 33°C and 37°C, was sufficient for developing 
stratified keratinocytes, HaCaT cells were grown in DMEM with 10% FBS on collagen coated PTFE 
Transwell membrane inserts. Upon confluency, which was reached after approximately 11 days of 
incubation at 37°C, cells were exposed to the air-liquid interface by removing the media from the upper 
chambers and replacing the spent media in the bottom chambers with KGM-Gold media supplemented 
with 10% FBS and 1.4mM CaCl2. The wells containing the inserts were then incubated at 33°C and 
37°C for 14 days and 24 days Fresh media was fed from the bottom chamber every other day.  
Inserts were then embedded in paraffin, cut in thin sections (3.5.1) and stained with H & E stain (3.5.2).  
Figure 4.1 shows the extent of stratification that had occurred in keratinocytes after 14 days of 
incubation at 33°C and 37°C compared to the keratinocyte stratification observed after 24 days of 
incubation at the same temperatures. Figure 1 shows that keratinocytes have the potential to stratify at 
33°C, regardless of the duration of incubation since more than one layer is depicted.   
Although stratification is seen after 14 days of incubation at 33°C and 37°C, the layering is more 
distinct and visible after incubation for 24 days at both temperatures. In addition, the keratinocyte 
layers that had formed after 24 days were more intact, looked more complete and resembled in vivo 
skin closer than those that were produced after only 14 days.   
 14 days  24 days  
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33°C  
37°C  
  
Figure 4.1: Comparison of differentiation of HaCaT cells grown at 33°C and 37°C for 14 days 
and 24 days ( X1000).   
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4.1.2 Dilutions of primary and secondary antibodies for Immunohistochemistry   
Cells grown at the air-liquid interface at 37°C for 24 days were prepared, cut into thin sections and 
placed on Apex BOND adhesive slides (Leica Biosystems Inc. Illinois, USA). Thereafter, the sections 
were prepared for immunohistochemistry (3.5.3) and stained with antibodies to Keratin 10, Keratin 14 
and Involucrin. Dilutions of 1:50 and 1:500 were prepared for the primary antibodies, whilst 1:100 
and 1:400 dilutions of FITC-conjugated secondary antibody were prepared. The optimal combination 
of dilutions of both antibodies was then determined.   
Figure 4.2A shows that fluorescence was detected after staining with the different combinations of 
antibody dilutions. For keratin 10 detection a 1:50 dilution of the primary antibodies and a 1:400 
dilution of the secondary antibodies gave the brightest fluorescence and was therefore used in 
experiments.  
The different combinations of antibodies to detect keratin 14 and involucrin all produced similar 
levels of fluorescence. However, the involucrin antibody combinations showed brighter fluorescence 
except for the combination of the highest dilutions. This is shown in Figures 4.2A and 4.2B. In the 
experiments the lowest dilutions of both antibodies were used for the detection of both.  
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Anti-Keratin 10 1:50 FITC-
conjugated secondary antibody 
1:100  
Anti-Keratin 10 1:50 FITC-
conjugated secondary 
antibody 1:400   
 
 
  
Anti-Keratin 10 1:500  Anti-Keratin 10 1:500  
 FITC-conjugated secondary  FITC-conjugated  
   antibody 1:100  secondary antibody 1:400  
 
  
Figure 4.2A: Comparison of fluorescence produced after staining thin sections of layered 
keratinocytes with various combinations of dilutions of primary and secondary antibodies to 
keratin 10 (X40).  
Anti-Keratin 14 1:50 FITC-
conjugated secondary antibody 
1:100  
Anti-Keratin 14 1:50  
FITC-conjugated secondary antibody 
1:400  
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 Anti-Keratin 14 1:500  Anti-Keratin 14 1:500  
 FITC-conjugated secondary  FITC-conjugated secondary  
   antibody 1:100  antibody 1:400  
 
  
Figure 4.2B: Comparison of fluorescence produced after staining thin sections of layered 
keratinocytes with various combinations of dilutions of primary and secondary antibodies to 
keratin 14 (X40).  
Anti-Involucrin 1:50 FITC-
conjugated secondary antibody 
1:100  
Anti-Involucrin 1:50 FITC-
conjugated secondary 
antibody 1:400  
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Anti-Involucrin 1:500  
FITC-conjugated secondary  
  antibody 1:100  
Anti-Involucrin 1:500 
FITC-conjugated secondary 
antibody 1:400  
 
  
Figure 4.2C: Comparison of fluorescence produced after staining thin sections of layered 
keratinocytes with various combinations of dilutions of primary and secondary antibodies to 
involucrin (X40).  
4.1.3 The use of organotypic co-cultures grown on a collagen matrix as an additional and alternate 
method to generate a stratified keratinocyte structure  
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Co-cultures of HaCaT cells and fibroblasts to generate a stratified in vitro model were performed as 
previously described by Stark et al, 1999. Briefly, collagen type 1 (4mg/ml) from rat’s tail (Sigma) was 
prepared by dissolving it in 0.1% acetic acid and mixing it with 10X HBSS. The pH of the mixture was 
then neutralized with 2M NaOH to pH 7. MRHF Human Dermal Fibroblasts were treated with 
mitomycin (0.4mg/ml) for 4 minutes at 37°C in order to halt replication. The non-dividing fibroblasts 
were trypsinized, enumerated in a haemocytometer, and mixed with the prepared collagen solution to 
reach a concentration of 6x105 cells/ml. This fibroblast suspension in collagen solution was cast onto 
polycarbonate Transwell filter inserts with pores of 3 µm diameter (Costar®). After 24 hours, HaCaT 
cells were seeded (1x106 cells/ml) onto the fibroblast containing collagen type 1 gels in the Transwell 
inserts. These co-cultures were incubated for 24 hours at 33°C and 37°C, after which media was 
replaced with DMEM supplemented with 10% FBS and 50 µg/ml L-ascorbic acid. Media was replaced 
three times per week.   
  
Once confluent, cells were exposed to the air-liquid interface and fed with DMEM supplemented with  
10% FBS, 50 µg/ml L-ascorbic acid, 2μg/ml TGF-α (R&D Systems) and 5μg/ml L-1 (R&D Systems). 
Once exposed to the air-liquid interface, inserts would have been incubated at their respective 
temperatures for an intended period of 24 days.   
It is for this reason that we reverted to commercially available collagen coated inserts, as seen in this 
study.   
  
Figure 4.3 shows that after just two weeks of incubation at 33°C and 37°C, the collagen present in the 
inserts had shrunk. HaCaT cells seeded onto the collagen and fibroblast mixture had not even reached 
confluency before the shrinkage had occurred. The collagen is seen as the white circles situated inside 
the inserts of the wells. The collagen is supposed to cover the surface area of the membrane insert for 
the entire incubation period. However, it was found that the collagen only covered a fraction of the 
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membrane. The level of shrinkage of the collagen on the inserts incubated at 37°C was more than on 
those incubated at 33°C.  
  
  
 
  
Figure 4.3: Collagen shrinkage in the fibroblast-keratinocyte co-cultures after 14 days of 
incubation at 33°C (a) and 37°C (b).  
  
4.2 Infection of stratified keratinocytes grown at 33°C and 37°C with Chlamydia trachomatis  
 HaCaT cell cultures on commercially available collagen coated PTFE Transwell membrane inserts 
were prepared as described in 3.3. Upon confluency, after approximately 11 days, cells were raised to 
the air-liquid interface and spent media in the bottom chamber was replaced every other day with 
fresh KGM-Gold media supplemented with 10 % FBS and 1.4 mM CaCl2. The cells were then 
incubated for 24 days at 33°C and 37°C. The HaCaT layers were then infected with C. trachomatis, 
L2 strain and incubated for a further week (3.4.).   
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The membrane inserts were then prepared for histology as described in 3.5.1.  
Figure 4.4 shows that with H&E staining there were no structural differences in the infected or 
uninfected keratinocyte layers incubated at 33°C (Figure 4 a and b). In contrast, the infected stratified 
keratinocyte layers incubated at 37°C was disintegrated compared to the uninfected control incubated 
at the same temperature (Figure 4.4 c and d). Furthermore, in comparison, the infected keratinocyte 
layers incubated at 33°C was less affected than the infected layer incubated at 37°C (Figure4.4 a 
compared to Figure 4.4 c). Although impairments are observed in the infected cell layers, multiple 
layers of keratinocytes are still seen in Figure 4.4.  
  
  
  
  
33°C   
  
  
  
  
  
37°C   
  
  
  
Figure 4.4: The comparison of the effect that Chlamydia trachomatis has on differentiated, 
polarised HaCaT cells at different temperatures.   
b  
c  d  
a  
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Images from H&E staining shows cells that were incubated at 33°C (a) and 37°C (c). Uninfected HaCaT 
structures were also incubated at 33°C (b) and 37°C (d) X1000.  
  
4.3 C. trachomatis infection of stratified HaCaT cells at 37oC and 33oC   
In order to demonstrate the effect that C. trachomatis has on stratified keratinocyte layers at 33°C and  
37°C, HaCaT cells grown at the air-liquid interface at the respective temperatures were infected with 
C.trachomatis and incubated for 7 days. The membrane inserts were then embedded in paraffin and 
sectioned (8 microns). In order to confirm infection with C. trachomatis, sections were stained with 
the Microtrak chlamydia trachomatis confirmation kit reagents. Sections were then viewed with the 
Invitrogen™ EVOS™ TL Cell imaging system.   
Figure 4.5 shows infection was successful at both temperatures with cells containing C. trachomatis 
inclusions. Infected cells fluoresce green and uninfected cells red. There are less red cells in the 
keratinocyte layers incubated at 37°C as compared those incubated at 33°C, indicating that more cells 
were infected at 37°C. This is in keeping with the observation (4.2) that the keratinocyte layers 
incubated at 37°C are more disintegrated and broken than at 33°C.    
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 33°C  37°C  
  
Figure 4.5: Chlamydia trachomatis infected layered keratinocytes stained with the MicroTrak ®  
C. trachomatis Culture Confirmation Test Kit reagents. Scale bar: 64μm (33°C); 125μm (37°C).  
Magnification: 70% (33°C); 50% (37°C).  
  
4.4 Differentiation of chlamydia infected HaCaT cells   
Membrane inserts with chlamydia infected keratinocyte layers as well as uninfected controls were 
processed as described in 3.5.1. The thin sections were stained with antibodies to keratin 10, keratin 
14 and involucrin.   
Figure 4.6 shows the presence of keratin 10, keratin 14 and incolucrin. For keratin 10 and involucrin, 
fluorescence is more intense at 33°C than 37°C. For keratin 14, fluorescence is more intense at 37°C.  
In addition, Figure 4.7 also shows that all sections from the structure of stratified keratinocytes 
incubated at 33°C were much more intact and unbroken compared to the brittle and disintegrated 
layers observed in the sections from structures incubated at 37°C, concurring with observations in  
Figures 4.4 and 4.5.     
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Figure 4.7 shows that non-specific binding of antibodies had not occurred after controls for 
nonspecific binding were prepared (3.5.3). White light images seen in Figure 4.7 b and d indicate the 
presence of the section, even though fluorescence was not detected.     
                                            
Keratin 10                                                             Keratin 14                                               Involucrin        
33°C 
 
     
37°C 
 
  
Figure 4.6: Confirmation of differentiation by the expression of keratinocyte markers (a-f).  
Scale bar (a-f): 100μm; 57μm; 43μm; 67μm; 100μm; 125μm.  
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33°C  
37°C  
Figure 4.7: Control demonstrating that non-specific binding had not occurred (a-d). Scale bar:  
125μm.   
  
4.5 Controls for stratification of keratinocytes    
In order to demonstrate the difference in the stratification and differentiation in keratinocytes after 7 
days of incubation at either temperature (33°C and 37°C), as opposed to that after 24 days of incubation,  
HaCaT cells were grown on PTFE collagen inserts for 7 days in KGM-Gold media supplemented with  
a                                                                                              b                                              
                                                                                                  
  
  
  
  
  
                                                                                                  
  
                                                                                             
  
  
  
c  d  
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10% FBS and 1.4 mM calcium at 33°C and 37°C. Inserts were embedded in paraffin and sectioned. H& 
E staining was then performed on the sections   
Figure 4.8 shows that only one solid and intact layer of keratinocytes was seen after 7 days of incubation 
at 33°C and 37°C, indicating that the keratinocytes had not stratified.   
  
 
Figure 4.8: H& E stain of the control which demonstrates the staining pattern in non-polarised, 
non-differentiated keratinocytes incubated for 7 days at 33°C (a X400 and b X1000) and 37° (c 
X400 and d X1000).   
  
  
  
  
  
  
  
   
  
  
  
  
  
  
a  b  
c  d  
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CHAPTER 5 – DISCUSSION   
  
Studies on stratification experiments have been limited mostly to primary human keratinocytes, which 
have been found to stratify and differentiate more easily and efficiently than keratinocytes cell lines 
(Lamb and Ambler, 2013).   
  
Our study focused on generating in vitro stratified keratinocyte layers using HaCaT cells grown on 
collagen-coated PTFE Transwell® membrane inserts, instead of aiding stratification with additional 
cytokines and growth factors such as TGF-α and KGF. The aim was to use this to study the 
pathogenesis of C. trachomatis, since its LGV biovar has human skin as its primary target.   
  
Methods to do so were first optimized for HaCaT cells. Stratification took place at both 33°C and 
37°C. Although stratification was more prominent in keratinocyte layers incubated at 37°C, the 
expression of keratin 10 and involucrin were more intense in layers incubated at 33°C. C. trachomatis 
infection was successful in cells grown at both temperatures. However, more infected cells were seen 
at 37°C than at 33°C.  
  
  
  
  
  
  
Marcello et al 1978, showed that after 3-4 days of incubation at 32°C - 33°C, a complete monolayer 
of Normal Epidermal Keratinocytes (NEKs) had formed and by 5-6 days, a second layer formed over 
the majority of the surface layer. These authors found that the upper layer constituted of cells with a 
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fibril network, allowing for a “basket weave” appearance of the keratinocytes. Stratification 
proceeded over 11 days in culture and after a total of 14 days, clumps of cells were visible. This 
primary keratinocyte model showed complete culture stratification, differentiation and proliferation 
after a 3 or more week incubation period. From this study (Marcello et al, 1978), it can be deduced 
that an incubation period of less than 3 weeks is not sufficient for stratification, differentiation and 
proliferation of keratinocytes. Our results with HaCaT cells shown in Figure 4.1 concur with these 
findings observed with NEK cells since a more intact HaCaT keratinocyte structure is seen after 
incubation for 24 days than after 14 days.  
Breitkreutz et al, 1998, reported that the differentiation of HaCaT cells improved after approximately 
21 days of incubation at 37°C, since typical features of differentiation, such as attachment structures 
and a basement membrane (BM) similar to NEKs were detected. Our study supports this finding (Fig  
4.1).  
Although more than one layer is seen in keratinocytes incubated for 14 days, thicker and clearer 
suprabasal layers are seen in keratinocytes incubated for 24 days. This indicates that HaCaT cells 
require three or more weeks to produce a differentiated and polarized structure comparable to human 
skin. It was for this reason that an incubation period of 24 days was used in all downstream 
experiments in this study, regardless of temperature.    
When preparing the membranes for histology, the membranes were left inside the inserts since these 
are extremely delicate and needed to be handled carefully. Having the cells on the membrane whilst it 
is still in the insert, as opposed to using a loose membrane, prevents potential damage to the cells.  
The manufacturer’s protocol for immunofluorescence staining called for heating of sections at 95°C 
(to facilitate antigen retrieval) in a microwave for two 5 minute intervals in a 10mM sodium citrate 
buffer, pH 3.5 with 0.01% (w/v) EDTA. However, there were no sections present on the slides after 
this step was conducted. To rule out the possibility of micro waving being too harsh, the sections were 
placed in a glass container with pre-heated 10mM sodium citrate buffer, pH 3.5 with 0.01% (w/v) 
EDTA. The container was then placed into a water bath at 95° for 10 minutes. This allowed for the 
sections to still be visible on the slides after heat-treatment.  
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A calcium gradient in the epidermis contributes towards the regulation of the process of 
differentiation in keratinocytes during their progression through various layers of the epidermis, 
eventually resulting in a permeable stratum corneum (Bikle et al. 2012). In our studies, the calcium 
concentration in the media was raised to 1.4mM in an effort to ensure that stratification and 
differentiation of HaCaT cells occurred. The KBM-Gold media, with which the cells were fed when 
exposed to the air-liquid interface, already had a calcium concentration of 0.1mM.   
  
Although the exact role of calcium in keratinocyte differentiation remains unknown (Shrestha et al. 
2016), it does affect signalling pathways such as the formation of desmosomes, adherens junctions 
and tight junctions (Bikle et al. 2012). In addition, the calcium receptor plays a pivotal role in 
promoting intracellular signalling processes which facilitate differentiation once extracellular calcium 
is detected (Bikle et al. 2012).  
  
An increase in the extracellular calcium concentration allows for the internal release of, and an influx 
of calcium through the respective calcium channels in the plasma membrane (Lee et al. 1991). In turn, 
this facilitates cell to cell adhesion (Hennings et al. 1983) and increases the intracellular free calcium 
concentration, which regulates the differentiation of keratinocytes (Hennings et al. 1981).  
  
Keratinocytes transcend from the stratum basale to the stratum corneum, and during that process they 
undergo terminal differentiation. This can be reproduced by growing keratinocytes in media that is 
enriched with a high calcium concentration (Henning et al. 1980). In vitro keratinocytes appear to look 
like basal epidermal cells and do not differentiate in media with a reduced calcium concentration (less 
than 0.03mM). However, at calcium concentrations over 0.1mM, keratinocytes resemble suprabasal 
epidermal cells and are seen to successfully differentiate (Hennings et al. 1981).  
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A study by Steven et al. 1983, which investigated the regulation of differentiation of NEKs by 
calcium, demonstrated that a calcium concentration of 0.3mM in the media, allowed for a 
colonyforming efficiency of 30% and a cellular multiplication rate of 0.96 doublings per day. An 
increased calcium concentration (0.1mM) allowed for stratification and terminal differentiation of the 
NEKs and this was determined by counting the number of cornified envelopes that remained after 
boiling in sodium dodecyl sulphate with dithithreitol.   
  
Similarly, another study by Hennings et al. 1980, investigated the role of calcium in the differentiation 
of cultured mouse keratinocytes. In an environment where calcium in the medium was approximately 
0.05mM-0.1mM, increased proliferation of the keratinocytes and production of keratin took place, 
albeit no stratification was seen. Upon ultrastructural examination after cells were subcultured in a 
reduced calcium environment, a vast majority of intracellular spaces was seen. The initiation of 
terminal differentiation was then conducted by increasing the concentration of calcium in the media to 
1.2mM, thereby substantially improving cell to cell contact and the formation of desmosomes in only 
2 hours. After 2 days, stratification of the cells was observed and terminal differentiation, indicated by 
cell sloughing, took place after 3 days.   
  
More recently, a study by Lamb and Ambler, 2013, investigated the stratification displayed by 
keratinocytes in various media types with varying concentrations of calcium.  Hematoxylin and eosin 
(H&E) staining showed that low calcium medium (0.05mM), supplemented with 10% serum did not 
result in the differentiation and stratification of NEKs. Contrastingly, cells grown in an environment 
with increased calcium (1.4mM) allowed for the production of two clearly visible layers of nucleated 
cells, indicating that an increased calcium environment is essential for the stratification and 
differentiation of keratinocytes.   
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In order to examine an alternate method of developing stratified keratinocyte layers with HaCaT cells, 
organotypic co-cultures of HaCaT cells and fibroblasts were grown on a collagen bed.  
Stromal interactions, initiated by IL-1 are required for differentiation and this cytokine is present in 
NEKs but reduced in HaCaT cells (Maas-Szabowski et al, 2003). These interactions allow for the 
subsequent production of various growth factors such as keratinocyte growth factor (KGF/FGF-7) and 
granulocyte macrophage-colony stimulating factor (GM-CSF) in fibroblasts (Maas-Szabowski et al. 
2001).  These factors in turn stimulate growth and differentiation of keratinocytes. The expression of 
the receptors for these growth factors in HaCaT cells is substantially reduced, suggesting that simply 
adding KGF and GM-CSF to the media, will not be sufficient to promote stratification and 
differentiation of the HaCaT cells (Maas-Szabowski et al. 2003). In addition, the release of the 
keratinocyte growth factor TGF-α is also reduced in HaCaT cells (Maas-Szabowski et al. 2003).    
  
Maas-Szabowski et al. 2003, investigated the stratification and differentiation of HaCaT cells grown 
as part of organotypic co-cultures with fibroblasts, with the addition of various growth factors and 
compared it to that seen in NEKs. The study found that co-cultures supplemented with TGF
IL-1 allowed for the increased expression of KGF and GM-CSF, thereby producing a differentiated 
and stratified model of HaCaT cells comparable to both, NEKS and human in vivo skin.   
We used the same method for growing organotypic co-cultures of HaCaT cells and fibroblasts in order 
to examine an alternate method of generating an in vitro model of stratified keratinocytes that closely 
resembled in vivo skin as opposed to only growing HaCaT cells at the air-liquid interface in PTFE-
collagen coated membrane inserts. However, the outcome of our attempt differed from the results seen 
by Maas-Szabowski et al. 2003 in that the collagen had shrunk after being incubated with fibroblast-
HaCaT co-cultures at both 33°C and 37°C (Figure 4.3).  
  
A study by Li and Wang, 2011, investigated the role of fibroblasts and myofibroblasts in wound 
healing. Cell traction forces allow fibroblasts and myofibroblasts to move throughout the extracellular 
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matrix (ECM) (Harris et al. 1981) and disrupt the ECM network, resulting in the regulation of cellular 
functions (Tranquillo et al. 1992), maintaining homeostasis with regards to cellular tension (Harris et 
al. 1987). In comparison, fibroblasts produce traction forces larger than those required for cellular 
movement (Harris et al. 1981) causing major disruptions of the cell ECM. More closely, during tissue 
repair, fibroblasts produced traction forces that caused contraction and disruption of the collagen 
matrix. In addition, a study by Elrich et al. 1990 showed that fibroblasts produced a traction force that 
caused single units to contract the wound and that myofibroblasts indicated the conclusion of the 
production of the contractile force.   
  
Taking the aforementioned studies into consideration, it may be assumed that the shrinkage of 
collagen observed in Figure 4.3 may have been as a result of the contractile forces of fibroblasts 
similar to what happens during wound healing. Since the collagen layer had shrunk to a much smaller 
size when incubated at 37°C (Figure 4.3 b), compared 33°C (Figure 4.3 a), it may be assumed that 
37°C is the optimum temperature for the cellular processes of fibroblasts, allowing for an increased 
production of the contractile force.   
  
In order to potentially generate a stratified keratinocyte structure using a method that involves 
growing organotypic co-cultures on a collagen bed, the amount of collagen used in the experiment 
would have to be optimized in order to counteract the amount of surface area that will be lost due to 
shrinkage. This method was not investigated further. However, it leaves room for additional studies.     
The in vitro keratinocyte layers were incubated at different temperatures to determine which of the 
two allowed for a closer resemblance to human skin in vivo. The two temperatures that were chosen 
for this experiment were 33°C and 37°C. This is because 37°C is core body temperature and 33°C is 
the temperature of human skin (Ramanathan, 1964).   
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All studies involving the development of a stratified keratinocyte model have used incubation at 37°C. 
Therefore, a model where HaCaT cells are grown at 33°C has not been studied before. In keeping 
with Lamb and Ambler, 2013, we detected the presence of keratin 10, keratin 14 and involucrin in 
cells grown at 37°C. Keratin 10, keratin 14 and involucrin were also detected in the cells that had 
been incubated at 33°C (Figure 4.6). This indicates that the keratinocytes in the stratification models 
incubated at both temperatures had committed to differentiation, although the keratin 10 and 
involucrin fluorescence was more intense at 33°C than at 37°C, whilst the fluorescence of keratin 14 
remained more intense at 37°C.   
  
As keratinocytes differentiate, there is detectable down-regulation of a specific set of basal proteins 
and the up-regulation of suprabasal markers (Fuchs, 1990). Keratins are expressed by epithelial tissue 
at specific sites and at specific stages of differentiation (Schweizer et al. 2006). It is for this reason 
that we looked for the presence of the basal marker keratin 14 and suprabasal markers keratin 10 and 
involucrin.   
  
Keratin 14 is part of the type I keratin family of intermediate filaments and is therefore involved in 
forming the cytoskeleton of epithelial cells and is expressed in mitotically active basal layer cells 
simultaneously with keratin 5 (Schweizer et al. 2006). As cells differentiate, expression is down 
regulated (Schweizer et al, 2006). Keratin 10, on the other hand, is expressed in post-mitotic, 
terminally differentiating keratinocytes (Paramio et al. 1999). During terminal differentiation, the 
cornified envelope develops in keratinocytes, causing cells to become permeable to both, calcium and 
various other ions (Thacher & Rice, 1985). This influx of calcium allows for the activation of 
transglutaminase which catalyses this process. (Thacher & Rice, 1985).  
  
Involucrin is an imperative precursor of the cell envelope. The mechanism by which Involucrin is 
positioned remains unknown, however it is placed adjacent to the inner plasma membrane and 
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crosslinked to a number of membrane proteins by keratin-specific transglutaminase (Thacher & Rice, 
1985). The sub-cellular localization of precursors and the involucrin amino acid sequence allows for 
the generation of the envelope and this process involves a minimum of 6 proteins (Thacher & Rice, 
1985).  
Figure 4.6 also shows that a more intense fluorescence is seen at 33°C for keratin 10 and involucrin 
compared to that seen at 37°C. This indicates a higher concentration of suprabasal markers, 
suggesting that even though stratification of keratinocytes was slower at 33°C than 37°C, 
differentiation was quicker at 33°C.  Gene expression studies on these two markers at different 
temperatures should be done in order to substantiate this finding.  
  
Figures 4.4 b and d show that more layers are formed during incubation at 37°C compared to 33°C, 
indicating that 37°C is a more suitable temperature to grow stratified keratinocyte layers. This may be 
because 37°C is the core body temperature (Ramanathan, 1964), giving an indication of how 
keratinocytes may grow in the human body.   
Additionally, further studies should be conducted where keratinocytes are grown at a temperature range 
from 30o to 37°C to better understand how in vivo keratinocyte growth does take place.  
  
After infection of the keratinocytes with chlamydia, the cells were incubated for both the experiments 
at 33oC and 37oC for a further week. The life cycle of the C. trachomatis L2 strain is approximately 48 
hours (Choroszy-krol et al. 2012). Therefore, incubating the infected keratinocyte layers for a week 
after infection ensured that EBs were released after the first cycle to infect new cells within the 
keratinocyte structure, allowing deeper penetration of the microorganisms into the keratinocyte layers.  
  
C. trachomatis infection experiments of multiple layers of HaCaT cells grown at 33°C have not been 
conducted before. Joubert and Sturm, 2008 showed that a monolayer of HaCaT cells grown at 33°C 
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could be infected with C. trachomatis, which is the approximate temperature at the initial target site 
during infection with the LGV biovar. The results of this study (Figure 4.5) show that C. trachomatis 
also infects layered keratinocytes at 33°C.    
  
Degradation seen in the infected keratinocyte layers incubated at 37°C was much more prominent 
compared to that incubated at 33°C (Fig 4.4 and 4.5). The layers formed at 33°C were not largely 
infected with C. trachomatis since there was a substantial amount of uninfected cells present at 33°C as 
compared to 37°C (Fig. 4.5). This is in keeping with former findings that the optimum growth 
temperature of the C. trachomatis LGV biovar is 37°C (Joubert and Sturm, 2008).  
  
Overall, the study provided an idea of the pathology of the C. trachomatis by demonstrating the effect 
it may have on in vivo skin. Similar keratinocyte models may be generated and infected with various 
other organisms in an effort to gain insight on the pathology thereof. In addition, the study may be 
explored further by documenting the effect of the organism on keratinocytes at various stages of the 
duration of incubation, giving a more detailed analysis of its pathology.   
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APPENDIX A   
  
Media, Solutions and Reagents  
  
1. Cell Culture Media   
  
1.1. Chlamydia Growth Media for Propagation  
  
20 ml EMEM with NEAA  
  1 ml EMEM 20X glucose (1.76g glucose in 20ml EMEM)   
0.02 ml Gentamycin   
0.02 ml Amphotericin B (10mg/ml)  
0.02 ml Cycloheximide (1mg/ml)  
  
Reagents were added and refrigerated until use  
  
1.2. All other cell culture media were used as purchased and respective supplements were 
added when necessary, as highlighted in Chapter 3  
  
2. Phosphate Buffered Saline (PBS) (Dulbecco A)  
  
5 PBS tablets (Oxoid)  
500ml distilled water  
81  
  
  
After dissolving 5 PBS tablets in 500ml autoclaved distilled water, the mixture was 
autoclaved at 121°C for 10 minutes, cooled and 20 ml aliquots were made in plastic tubes for 
refrigeration until use.  
3. 0.05% EDTA  
  
0.05g EDTA  
1 PBS Tablet   
100 ml Distilled water   
  
After dissolving 1 PBS tablet and 0.05g EDTA in ~80ml autoclaved water, the pH was 
adjusted to 7.4 by adding 7.5% Sodium bicarbonate. Thereafter, the volume was adjusted to 
100 ml and the mixture was autoclaved at 121°C for 10 minutes. 1 ml aliquots were then 
prepared for refrigeration until use.  
  
4. Storage Fluid  
  
4.1. HaCaT Cell Storage Fluid   
  
30 ml Hyclone DMEM  
10 ml Glycerol (BDH Laboratory supplies, Poole, England)  
10 ml FBS   
  
10 ml FBS and 10 ml Glycerol were added to 30 ml Hyclone DMEM and filter sterilized 
through a 0.22μm filter into a sterile 50ml tube.   
  
4.2. McCoy Cell Storage Fluid   
  
82  
  
30 ml EMEM with EBSS, NEAA, sodium pyruvate, L-glutamine and HEPES   
10 ml dimethyl sulphoxide (DMSO) (Fluka, Steinheim, Germany)   
10 ml FBS    
  
10 ml DMSO and 10ml of FBS were added to 30ml of EMEM and filter-sterilized through 
a 0.22µm filter into a sterile tube.  
  
5. MicroTrak® C. trachomatis Reagent  
  
5.1. MicroTrak® C. trachomatis Culture Confirmation Test:   
  
C. trachomatis reagent: Fluorescein-labelled mouse monoclonal antibodies specified to C. 
trachomatis; protein-stabilized phosphate buffer; Evans Blue counter-stain, 0.01% sodium 
azide   
  
Diluent: deionized water; 0.1% sodium azide    
3 ml reconstitution diluent was added to lyophilized C. trachomatis reagent and gently 
swirled in order to dissolve. The reconstitution date was recorded on the vial, which was 
allowed to reach room temperature after approximately 15 minutes. Thereafter, the vial could 
be refrigerated (2-8°C) for up to 12 weeks.   
  
5.2. Sucrose-Phosphate-Glutamate Buffer (SPG)  
  
Sucrose  
KH2PO4  
Na2HPO4. 7H2O  
Glutamic Acid  
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Distilled water  
  
The Sucrose, KH2PO4, Na2HPO4.7H2O and Glutamic Acid were dissolved in ~400 ml 
autoclaved distilled water and the pH was adjusted to 7.4 by adding 7.5% Sodium 
bicarbonate. Thereafter, the volume was brought to 500 ml and the solution was filter 
sterilized through a 0.22 0.22µm filter into a sterile tube and stored at -20°C until use.   
  
6. Immunofluorescence   
  
6.1. Primary Antibodies   
  
Antibodies to keratin 10, keratin 14 and involucrin were diluted in PBS and 1.5% Goat 
serum as follows:  
  
1:50   – 20 μl antibody was added to 980 μl PBS + Goat Serum Solution  
1:500 – 2 μl antibody was added to 998 μl PBS + Goat Serum Solution   
  
6.2. Secondary Antibodies  
Secondary antibody conjugated to FITC were diluted in PBS and 1.5% Goat serum as 
follows:  
  
1:100 – 10 μl antibody was added to 990 μl PBS + Goat Serum Solution   
1:400 – 2.5 μl antibody was added to 997.5 μl PBS + Goat Serum Solution   
  
6.3. 1.5% Goat Serum   
  
0.15 ml Goat Serum  
9.85 ml PBS  
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0.15 ml Goat serum was added to 9.85 ml PBS and refrigerated until use   
  
  
6.4. Soudium Citrate Buffer   
  
2.94g Tri Sodium Citrate (dihydrate)  
1000ml distilled water  
  
2.94g Tri Sodium Citrate (dehydrate) was dissolved to 1000 ml distilled water and the pH 
was adjusted to 6.0 by adding hydrochloric acid   
  
6.5. Blocking Serum   
  
0.5 ml Goat serum   
4.5 ml PBS   
  
0.5 ml Goat serum was added to 4.5 ml PBS and refrigerated until use  
  
7. Preparation of collagen and organotypic co-cultures   
  
7.1. 5 mg Collagen from rat’s tail (Sigma)  
0.1% acetic acid  
0.15 ml 10X HBSS  
  
5 mg collagen was dissolved in 0.1% acetic acid on ice. The solution was then added to 
0.15 ml 10X HBSS and neutralized with 2M NaOH  
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7.2. Mitomycin   
  
120 mg Mitomycin was dissolved in 30 ml autoclaved distilled water and alliquotted into 1 ml 
tubes and refrigerated for use  
  
   
  
  
